The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
about
Prediction of the pharmacokinetic parameters of triptolide in rats based on endogenous molecules in pre-dose baseline serumPharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers.Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitisNonlinear intestinal absorption kinetics of cefuroxime axetil in rats.Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteersPharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up.Pharmacokinetics and bactericidal activity of cefuroxime axetil.Cefuroxime axetil for treatment of uncomplicated gonorrheaPharmacokinetic analysis of the effects of different foods on absorption of cefaclor.Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.New semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics.Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation.The dilemma of monotherapy or combination therapy in community-acquired pneumonia.Bioequivalence evaluation of two brands of cefuroxime 500 mg tablets (Cefuzime and Zinnat) in healthy human volunteers.
P2860
Q28482330-30E1ADA2-D57B-4987-95CC-D98428C8218CQ33742875-39EFE2A3-B65A-4BFC-8120-BDFA1A9540A4Q35120327-46101726-F145-48CC-B520-F2AAAA1A8825Q35132726-FF41064B-25A8-4622-BE9F-C730240A299AQ35269538-653DA588-4A8A-46E3-8FF1-04E9BFE2EEF5Q35300598-86FB9C9E-4B8F-43F3-A54C-CBC829099469Q35541863-8F56B63D-988A-49D8-A4BC-45E6E5DEC1B6Q35647337-481B9061-8754-4195-8F34-F23EA9191FC5Q35651955-C611193E-FB75-438E-99EA-B387EF1151E7Q36754745-D099FC44-CF39-48CD-968A-FF529EE0D920Q36754904-1529A8EF-B853-4B0B-8E17-2576F3F35895Q37274639-F25E493B-64D0-4D70-9F65-8A0349D5ED0FQ37361046-21571BB2-4161-4AF3-A91D-FC55D7C2DDCEQ47291065-57D21E4C-3857-48DF-86AA-2C53FC3DE06BQ51549676-04C9E52F-1FA5-434A-87DF-D5F553109A9F
P2860
The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
The absolute bioavailability o ...... after fasting and after food.
@en
The absolute bioavailability o ...... after fasting and after food.
@nl
type
label
The absolute bioavailability o ...... after fasting and after food.
@en
The absolute bioavailability o ...... after fasting and after food.
@nl
prefLabel
The absolute bioavailability o ...... after fasting and after food.
@en
The absolute bioavailability o ...... after fasting and after food.
@nl
P356
P1476
The absolute bioavailability o ...... after fasting and after food.
@en
P2093
Harding SM
Williams PE
P304
P356
10.1093/JAC/13.2.191
P407
P577
1984-02-01T00:00:00Z